Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Thrombocytopenia: investigation

Haematology and transfusion · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Active major bleeding, new neurological or renal dysfunction with haemolysis, pregnancy hypertension with organ injury, suspected DIC, or a platelet fall with thrombosis after heparin requires immediate senior and haematology assessment. Review the blood film urgently for schistocytes and blasts. When immune TTP is plausible, send ADAMTS13 before plasma if feasible but begin the specialist treatment pathway without waiting for the result.

Synopsis

Confirm a genuine low platelet count, use film and clinical context to separate production, destruction, consumption and sequestration, and identify TTP, DIC, HIT and critical bleeding without delay.

  • Confirm that thrombocytopenia is real: EDTA-dependent platelet clumping, difficult sampling and platelet satellitism can produce a spuriously low automated count.
  • Repeat the count in a citrate or other validated alternative tube and inspect a blood film when clumping or an unexpected isolated result is reported.
  • First determine urgency from bleeding, physiology, neurological or renal features, pregnancy, sepsis, thrombosis and the direction and speed of count change.
  • The blood film can reveal schistocytes, blasts, dysplasia, giant platelets, malaria, clumping and a leucoerythroblastic pattern and should be reviewed early.
  • Isolated thrombocytopenia with otherwise normal film and no systemic illness suggests ITP or a drug effect after HIV, hepatitis and other secondary causes are considered.
  • Anaemia with schistocytes, raised LDH and low haptoglobin indicates microangiopathic haemolysis and activates TTP, HUS, DIC, malignant hypertension or pregnancy pathways.
  • Prolonged PT and APTT, low fibrinogen and high D-dimer support consumptive DIC in the right clinical setting but normal early coagulation does not exclude evolution.
  • A fall beginning five to ten days after heparin with new thrombosis is assessed using the 4Ts score before PF4 laboratory testing and alternative anticoagulation.
  • Liver disease and splenomegaly cause sequestration, while alcohol, medicines, B12 or folate deficiency, marrow failure and malignancy reduce platelet production.
  • Do not transfuse platelets simply because the count is low; bleeding, procedure, mechanism and diagnosis determine benefit, and platelets can be harmful in TTP or HIT.

Key red flags

TTP emergency

Thrombocytopenia plus microangiopathic haemolysis and neurological, renal or abdominal features requires immediate plasma-exchange service contact.

Investigation priorities

01
Repeat count and alternative-anticoagulant sampleFirst step

Confirm genuine thrombocytopenia and remove EDTA-related artefact.

Management branches

ConfirmationVerify the number without missing danger

An analyser reports a new low platelet count.

  1. Assess active bleeding, haemodynamics, neurology, kidneys, pregnancy, sepsis, thrombosis and recent heparin before repeating a clinically unexpected count.
  2. Request an urgent film and repeat in citrate or another validated tube if clumping is possible, while comparing the complete historical trajectory.
  3. Escalate schistocytes, blasts, major bleeding or organ dysfunction immediately rather than waiting for a routine outpatient recheck.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • British Society for Haematology thrombocytopenia guidanceConfirmation, film, differential diagnosis and referral principles.
  • British Society for Haematology TMA guidelineMicroangiopathic pattern, ADAMTS13 and urgent treatment.
  • NICE blood transfusion recommendationsPlatelet thresholds, procedure support, exclusions and reassessment.
  • NICE suspected cancer recommendationsUrgent referral for abnormal counts and haematological malignancy features.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom